Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Botanisol

Botanisol?uq=kzBhZRuG
2012 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Angel LATEST DEAL TYPE
$20K LATEST DEAL AMOUNT
1 INVESTORS
Description

Developer of anti-inflammatory drugs. The company develops non-steroidal anti-inflammatory drugs from bio-active constituents of plants that are natural and organic and pose lesser threat to human bodies.

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Other Pharmaceuticals and Biotechnology
Primary Office
  • 32531 North Scottsdale Road
  • Suite 105
  • Scottsdale, AZ 85266
  • United States

+1 (657) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Botanisol’s full profile, request a free trial.

Botanisol Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Angel (individual) 01-Sep-2016 $20K Completed Startup
1. Grant 09-Aug-2015 00000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Botanisol Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
U.S. Department of Health and Human Services Government 000 0000 000000 0

Botanisol Executive Team (3)

Name Title Board
Seat
Contact
Info
P Waterhouse Ph.D Co-Founder & Chief Executive Officer
David Gang Ph.D Co-Founder & Chief Scientific Officer
David Talenfeld JD Board Member & Managing Member

Botanisol Board Members (1)

Name Representing Role Since Contact
Info
David Talenfeld JD Botanisol Board Member & Managing Member 000 0000